Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$2.70
+0.4%
$6.55
$2.33
$39.00
$2.06M0.8866,661 shs71,785 shs
FAP
abrdn Asia-Pacific Income Fund VCC
C$2.95
+0.3%
C$2.91
C$2.67
C$3.04
C$108.75M0.5456,461 shs18,834 shs
Olympia Financial Group Inc. stock logo
OLY
Olympia Financial Group
C$131.00
-0.5%
C$124.13
C$95.51
C$134.24
C$315.23M0.271,944 shs1,060 shs
Consumer Discretionary Select Sector SPDR Fund stock logo
XLY
Consumer Discretionary Select Sector SPDR Fund
$233.10
+3.0%
$221.21
$173.10
$240.28
$23.40B1.184.51 million shs7.46 million shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
+0.37%+1.89%-68.05%-70.46%-93.15%
FAP
abrdn Asia-Pacific Income Fund VCC
+0.34%+0.68%+1.37%+0.68%+6.50%
Olympia Financial Group Inc. stock logo
OLY
Olympia Financial Group
-0.54%-0.15%+5.65%+23.54%+16.86%
Consumer Discretionary Select Sector SPDR Fund stock logo
XLY
Consumer Discretionary Select Sector SPDR Fund
+3.04%+1.77%+2.89%+10.66%+24.27%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
1.4161 of 5 stars
3.50.00.00.02.10.00.0
FAP
abrdn Asia-Pacific Income Fund VCC
N/AN/AN/AN/AN/AN/AN/AN/A
Olympia Financial Group Inc. stock logo
OLY
Olympia Financial Group
3.0327 of 5 stars
2.50.02.50.01.93.31.3
Consumer Discretionary Select Sector SPDR Fund stock logo
XLY
Consumer Discretionary Select Sector SPDR Fund
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
3.00
Buy$275.0010,085.19% Upside
FAP
abrdn Asia-Pacific Income Fund VCC
0.00
N/AN/AN/A
Olympia Financial Group Inc. stock logo
OLY
Olympia Financial Group
3.00
BuyC$147.9112.91% Upside
Consumer Discretionary Select Sector SPDR Fund stock logo
XLY
Consumer Discretionary Select Sector SPDR Fund
2.67
Moderate Buy$233.10N/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$121K17.05N/AN/A$0.20 per share13.50
FAP
abrdn Asia-Pacific Income Fund VCC
C$14.12M7.70C$0.45 per share6.60C$2.92 per share1.01
Olympia Financial Group Inc. stock logo
OLY
Olympia Financial Group
C$102.64M3.07C$11.24 per share11.66C$16.72 per share7.83
Consumer Discretionary Select Sector SPDR Fund stock logo
XLY
Consumer Discretionary Select Sector SPDR Fund
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
-$28.96M-$24.68N/AN/AN/A-12,594.21%-421.73%-147.54%N/A
FAP
abrdn Asia-Pacific Income Fund VCC
C$11.23MC$0.319.65N/A79.52%10.17%2.92%N/A
Olympia Financial Group Inc. stock logo
OLY
Olympia Financial Group
C$24.45MC$10.1612.89N/A23.82%64.95%35.88%N/A
Consumer Discretionary Select Sector SPDR Fund stock logo
XLY
Consumer Discretionary Select Sector SPDR Fund
N/AN/A27.10N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/AN/AN/AN/AN/A
FAP
abrdn Asia-Pacific Income Fund VCC
C$0.217.12%N/A68.71%N/A
Olympia Financial Group Inc. stock logo
OLY
Olympia Financial Group
C$7.205.50%N/A70.86%N/A
Consumer Discretionary Select Sector SPDR Fund stock logo
XLY
Consumer Discretionary Select Sector SPDR Fund
$1.820.78%N/AN/AN/A

Latest FAP, OLY, AIM, and XLY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/20/2025
Olympia Financial Group Inc. stock logo
OLY
Olympia Financial Group
MonthlyC$0.605.76%8/20/20258/29/20258/29/2025
7/22/2025
Olympia Financial Group Inc. stock logo
OLY
Olympia Financial Group
MonthlyC$0.605.95%7/22/20257/31/20257/31/2025
6/19/2025
Olympia Financial Group Inc. stock logo
OLY
Olympia Financial Group
MonthlyC$0.606.28%6/19/20256/30/20256/30/2025
6/10/2025
FAP
abrdn Asia-Pacific Income Fund VCC
jun 25C$0.026/23/20251/1/2000
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
0.05
0.75
0.75
FAP
abrdn Asia-Pacific Income Fund VCC
44.38
2.85
0.30
Olympia Financial Group Inc. stock logo
OLY
Olympia Financial Group
6.00
3.32
1.59
Consumer Discretionary Select Sector SPDR Fund stock logo
XLY
Consumer Discretionary Select Sector SPDR Fund
N/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
20764,00068.74 millionNot Optionable
FAP
abrdn Asia-Pacific Income Fund VCC
N/A36.86 millionN/ANot Optionable
Olympia Financial Group Inc. stock logo
OLY
Olympia Financial Group
3252.41 millionN/ANot Optionable
Consumer Discretionary Select Sector SPDR Fund stock logo
XLY
Consumer Discretionary Select Sector SPDR Fund
147,000100.40 millionN/ANot Optionable

Recent News About These Companies

Consumer Strength Signal Flashing Short-Term Caution Sign
Are Cyclical ETFs Worth the Boom and Bust?
What Tariffs Mean for Your Sector Exposure

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AIM ImmunoTech stock logo

AIM ImmunoTech NYSE:AIM

$2.70 +0.01 (+0.37%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$2.67 -0.03 (-1.11%)
As of 08/22/2025 07:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat human papilloma viruses, and genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with Amarex Clinical Research LLC; University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente; Jubilant HollisterStier; Sterling Pharma Solutions; Erasmus University Medical Center Rotterdam; Azenova, LLC; and Alcami Corporation. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.

abrdn Asia-Pacific Income Fund VCC TSE:FAP

C$2.95 +0.01 (+0.34%)
As of 08/22/2025 03:58 PM Eastern

The investment objective of the Company is to obtain current income and achieve incidental capital appreciation from investment in long-term securities. The Company seeks to obtain these objectives primarily from investment in long-term debt securities. The Company may invest up to 100 percent of its total assets in Asia-Pacific debt securities.

Olympia Financial Group stock logo

Olympia Financial Group TSE:OLY

C$131.00 -0.71 (-0.54%)
As of 08/22/2025 03:56 PM Eastern

Olympia Financial Group Inc is engaged in providing financial services. The company's operating segments are Private Health Services Plan division which markets, sells and administers health and dental benefits to business owners; Investment Account Services division specializes in registered account administration; The Currency and Global Payments division provides corporations and private clients a personalized service for buying and selling foreign currencies; The Exempt Edge division is focused on Onboarding fees; The Corporate and Shareholder Services division, which acts as a cost centre and the Corporate Division.

Consumer Discretionary Select Sector SPDR Fund stock logo

Consumer Discretionary Select Sector SPDR Fund NYSEARCA:XLY

$233.10 +6.87 (+3.04%)
Closing price 08/22/2025 04:10 PM Eastern
Extended Trading
$233.50 +0.40 (+0.17%)
As of 08/22/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Consumer Discretionary Select Sector SPDR Fund seeks to provide investment results that correspond generally to the price and yield performance of the Consumer Discretionary Select Sector Index (the Index). The Index includes companies from the following industries, media; retail (specialty, multiline, Internet and catalog); hotels, restaurants and leisure; textiles, apparel and luxury goods; household durables; automobiles; auto components; distributors; leisure equipment and products; and diversified consumer services. The Fund's investment advisor is SSgA Funds Management, Inc.